293 related articles for article (PubMed ID: 36422545)
1. Implications of Fragment-Based Drug Discovery in Tuberculosis and HIV.
Mallakuntla MK; Togre NS; Santos DB; Tiwari S
Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36422545
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges.
Togre NS; Vargas AM; Bhargavi G; Mallakuntla MK; Tiwari S
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142582
[TBL] [Abstract][Full Text] [Related]
4. Fragment-based approaches to anti-HIV drug discovery: state of the art and future opportunities.
Huang B; Kang D; Zhan P; Liu X
Expert Opin Drug Discov; 2015 Dec; 10(12):1271-81. PubMed ID: 26372893
[TBL] [Abstract][Full Text] [Related]
5. Fragment Based Strategies for Discovery of Novel HIV-1 Reverse Transcriptase and Integrase Inhibitors.
Latham CF; La J; Tinetti RN; Chalmers DK; Tachedjian G
Curr Top Med Chem; 2016; 16(10):1135-53. PubMed ID: 26324045
[TBL] [Abstract][Full Text] [Related]
6. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
7. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on Fragment-based Drug Discovery: A Strategy Applicable to Diverse Targets.
Li Q; Kang C
Curr Top Med Chem; 2021; 21(13):1099-1112. PubMed ID: 34348623
[TBL] [Abstract][Full Text] [Related]
9. Application of Fragment-Based Drug Discovery to Versatile Targets.
Li Q
Front Mol Biosci; 2020; 7():180. PubMed ID: 32850968
[TBL] [Abstract][Full Text] [Related]
10. Fragment-based drug discovery-the importance of high-quality molecule libraries.
Bon M; Bilsland A; Bower J; McAulay K
Mol Oncol; 2022 Nov; 16(21):3761-3777. PubMed ID: 35749608
[TBL] [Abstract][Full Text] [Related]
11. Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis.
Urban M; Šlachtová V; Brulíková L
Eur J Med Chem; 2021 Feb; 212():113139. PubMed ID: 33422979
[TBL] [Abstract][Full Text] [Related]
12. Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach.
Madugula SS; Nagamani S; Jamir E; Priyadarsinee L; Sastry GN
Mol Divers; 2022 Jun; 26(3):1675-1695. PubMed ID: 34468898
[TBL] [Abstract][Full Text] [Related]
13. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
14. In Silico Structure-Based Approach for Group Efficiency Estimation in Fragment-Based Drug Design Using Evaluation of Fragment Contributions.
Shulga DA; Ivanov NN; Palyulin VA
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335347
[TBL] [Abstract][Full Text] [Related]
15. Drug discovery in tuberculosis. New drug targets and antimycobacterial agents.
Campaniço A; Moreira R; Lopes F
Eur J Med Chem; 2018 Apr; 150():525-545. PubMed ID: 29549838
[TBL] [Abstract][Full Text] [Related]
16. Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon.
Bhat ZS; Rather MA; Maqbool M; Ahmad Z
Biomed Pharmacother; 2018 Jul; 103():1733-1747. PubMed ID: 29864964
[TBL] [Abstract][Full Text] [Related]
17. Advances in fragment-based drug discovery platforms.
Orita M; Warizaya M; Amano Y; Ohno K; Niimi T
Expert Opin Drug Discov; 2009 Nov; 4(11):1125-44. PubMed ID: 23480433
[TBL] [Abstract][Full Text] [Related]
18. In silico fragment-based drug design.
Konteatis ZD
Expert Opin Drug Discov; 2010 Nov; 5(11):1047-65. PubMed ID: 22827744
[TBL] [Abstract][Full Text] [Related]
19.
Jagadeb M; Rath SN; Sonawane A
J Biomol Struct Dyn; 2019 Aug; 37(13):3388-3398. PubMed ID: 30132739
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]